Title : Biomodulation of an implant for enhanced bone-implant anchorage.

Pub. Date : 2019 Sep 15

PMID : 31301423






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In an animal model, a calcium sulphate (CaS)/hydroxyapatite (HA) carrier was used to provide a spatio-temporal release of bone morphogenic protein-2 (BMP-2) and zoledronic acid (ZA). Durapatite bone morphogenetic protein 2 Rattus norvegicus
2 In an animal model, a calcium sulphate (CaS)/hydroxyapatite (HA) carrier was used to provide a spatio-temporal release of bone morphogenic protein-2 (BMP-2) and zoledronic acid (ZA). Durapatite bone morphogenetic protein 2 Rattus norvegicus
3 In an animal model, a calcium sulphate (CaS)/hydroxyapatite (HA) carrier was used to provide a spatio-temporal release of bone morphogenic protein-2 (BMP-2) and zoledronic acid (ZA). Durapatite bone morphogenetic protein 2 Rattus norvegicus
4 In an animal model, a calcium sulphate (CaS)/hydroxyapatite (HA) carrier was used to provide a spatio-temporal release of bone morphogenic protein-2 (BMP-2) and zoledronic acid (ZA). Durapatite bone morphogenetic protein 2 Rattus norvegicus